- Home
- BC vs APLS Comparison
BC vs APLS Comparison
Compare BC & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BC
- APLS
- Stock Information
- Founded
- BC 1845
- APLS 2009
- Country
- BC United States
- APLS United States
- Employees
- BC N/A
- APLS N/A
- Industry
- BC Homebuilding
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- BC Consumer Discretionary
- APLS Health Care
- Exchange
- BC Nasdaq
- APLS Nasdaq
- Market Cap
- BC 3.6B
- APLS 3.5B
- IPO Year
- BC N/A
- APLS 2017
- Fundamental
- Price
- BC $62.92
- APLS $25.48
- Analyst Decision
- BC Buy
- APLS Buy
- Analyst Count
- BC 13
- APLS 20
- Target Price
- BC $65.23
- APLS $33.47
- AVG Volume (30 Days)
- BC 696.2K
- APLS 2.3M
- Earning Date
- BC 10-23-2025
- APLS 11-04-2025
- Dividend Yield
- BC 2.70%
- APLS N/A
- EPS Growth
- BC N/A
- APLS N/A
- EPS
- BC 0.63
- APLS N/A
- Revenue
- BC $5,097,000,000.00
- APLS $754,649,000.00
- Revenue This Year
- BC $1.58
- APLS $22.11
- Revenue Next Year
- BC $4.59
- APLS N/A
- P/E Ratio
- BC $101.36
- APLS N/A
- Revenue Growth
- BC N/A
- APLS 20.02
- 52 Week Low
- BC $41.00
- APLS $16.10
- 52 Week High
- BC $87.65
- APLS $35.72
- Technical
- Relative Strength Index (RSI)
- BC N/A
- APLS 59.42
- Support Level
- BC N/A
- APLS $21.07
- Resistance Level
- BC N/A
- APLS $25.41
- Average True Range (ATR)
- BC 0.00
- APLS 0.78
- MACD
- BC 0.00
- APLS 0.30
- Stochastic Oscillator
- BC 0.00
- APLS 96.66
About BC Brunswick Corporation
Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns numerous Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.